Key facts
- This page summarizes John Bencich's Form 4 filing for ACHIEVE LIFE SCIENCES, INC. (ACHV).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 24 Jan 2024, 18:54.
John Bencich - 22 Jan 2024 Form 4 Insider Report for ACHIEVE LIFE SCIENCES, INC. (ACHV)
- Reporting relationship
- CEO, Director
- Issuer ticker
- ACHV
- Reported as of
- 22 Jan 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Jan 2024, 18:54:45 UTC
- Prior SEC filing
- 01 Jun 2023
- Next SEC filing
- 06 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- Sandra Thomson as attorney-in-fact for John Bencich
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John Bencich filed Form 4 for ACHIEVE LIFE SCIENCES, INC. (ACHV) on 24 Jan 2024.
Change
- Previous filing in this sequence was filed on 01 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ACHV
transaction
Derivative
Performance Restricted Stock Unit (PRSU)
Award
- Transaction value
- $0
- Shares
- +175,000
- Change %
- Price
- $0.000000
- Shares after
- 175,000
- Date
- 22 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 175,000
- Exercise price
- Footnotes
- F1, F2
ACHV
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +75,000
- Change %
- Price
- $0.000000
- Shares after
- 75,000
- Date
- 22 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $4.55
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
Footnote F2
Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones being met. The PRSUs will lapse in full if achievement of at least one of the milestones is not met.
Footnote F3
The options vest one-third on the first anniversary of January 22, 2024 and thereafter in monthly installments over 24 months.